Financial and Regulatory
Your smart tech partner in natural health
2022 Q2 Financial Statements
2022 Q2 MD&A
2022 Q3 Financial Statements
2022 Q3 MD&A
Visit us at SEDAR
PanGenomic Prospectus (PDF)
Number of securities in issue and the percentage of securities in public hands.
99,128,169 common shares outstanding 88.6% held publicly.
Particulars of any outstanding instruments issued by the issuer convertible into, or conferring a right to subscribe for, the admitted securities; the amount and percentage of immediate dilution assuming full exercise of rights of conversion.
4,150,000 Stock options at $0.15
500,000 warrants at $0.10
3,000,000 warrants at $0.15
25,607,045 warrants at $0.30
No restrictions on any transfers.
Shareholders holding more than five percent of the issuer's share capital or voting rights and the percentage held by such shareholders
No shareholders currently hold more than 5% of the issuer’s share capital.